Small biotechs shoulder the burdens of an uncertain biopharma sector
Recent US tariffs and federal funding cuts mean a heightened uncertainty for biopharma investors, and small biotechs are set to…
All articles by Frankie Fattorini
Frankie Fattorini
Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.
-
-
Trump order eases Medicare price negotiation for small molecule drugs
US President Donald Trump has issued a broad executive order to lower prescription drug prices in the country, notably including…
-
Can AI replace medical writers? Experts say not immediately
Artificial intelligence (AI) is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but…
-
Streeting promises UK pharma quick action on VPAG frustration
The UK pharma industry can expect resolutions on a range of issues, including VPAG [Voluntary Scheme for Branded Medicines Pricing…
-
ABPI calls on UK Government to resolve “VPAG crisis”
Leaders of the Association of the British Pharmaceutical Industry (ABPI) say the UK Government must address rising clawback rates on…
-
Saving shelved ultra-rare therapies through unorthodox funding
As a funding drought for biopharma is on the horizon, non-profit biotech Orphan Therapeutics Accelerator is championing an innovative funding…
-
Allogeneic cell therapies “poised for prime time” says expert
As cell and gene therapy developers struggle against an investment slump and competition from established autologous treatments, allogeneic cell therapies…
-
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
-
Are European biopharma manufacturers ‘nearshoring’?
In step with international news in recent times, European pharma and biotech are leaning towards ‘nearshoring’, preferring domestic operations to…
-
Machine learning adoption into supply chain management on the horizon
Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years away,…